🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

For any @ViewRay users at #ASTRO23 — given recent events and the apparent outcome in the last few hours, we need to talk as a global users’ group. DM me your name, affiliation and number if you want to participate in a WhatsApp group 💪 Paul Gearing Himanshu Nagar

Despite the debate around #MRgRT its impact on #radonc is undeniable. The inability for sites to continue using #MRIdian still seems like a bad dream. But it will soon become reality and patients w/o question are those who immensely lose. What a complete and utter shame.

It is bittersweet that the initial phase 2 SMART pancreas trial results are now in press IJROBP - The Red Journal as ViewRay finalizes the bankruptcy process. Congrats to Parag Parikh and the entire study team for completing this trial, which many doubted could be done. redjournal.org/article/S0360-…

Without a quick and comprehensive resolution, the #MRIdian platform will disappear. Patients will miss out, and technical innovation in radiotherapy will be derailed. But we will not go quietly into that good night… read our open letter to the #radonc community👍

Today, with due diligence, we successfully treated our very first patient (#PancreaticCancer) using #SMART on ViewRay #MRIdian City of Hope City of Hope | Orange County. This fulfills one of our commitment to our cancer patients in #OrangeCounty, #SoCal, and beyond! #MRgRT

A review of SBRT clinical trial pubs reveals significant variability in technical and dosimetric data, often missing key information needed for replicating procedures. Pre-trial QA in 45%. No study fully met criteria for technical reproducibility. #radonc pubmed.ncbi.nlm.nih.gov/38043902/

🔥🔥 Long-term outcomes from phase 2 SMART pancreas trial now in press 🔥🔥 ➡️ 136 BRPC/LAPC pts, 50 Gy/5 fx on #MRidian ➡️ Median F/U 22.9 mo from dx, 14.2 mo from SMART ➡️ 2-yr OS 53.6% from dx, 40.5% from SMART ➡️ Grade 3+ late GI toxicity minimal sciencedirect.com/science/articl…

Saw last patient of the year today Solitary gastric cancer recurrence surrounded by bowel after subtotal gastrectomy, stable on chemo 👉 50 Gy/5 fx 👉 adapted plan daily since tumor position shifted A LOT! 👉 4 mo later CR, feeling swell 😎 What a way to close out 2023 🎉🎉

ASTRO requests feedback on the draft Quality and Safety Considerations for Adaptive Radiation Therapy: An ASTRO Safety White Paper. Submit comments via the webform by Sunday, Feb. 11. Learn more: ow.ly/BnOr50Qu7lY

Thankful for the collaborative rallying that succeeded to continue on with this life saving tech/MRgRT for our patients and the field. ViewRay #ViewRaySystems #Innovation #radonc #medphys #Collaboration #MRgRT #MRLinac

ART, BgRT, Photon-counting CT, MRgRT, Functional avoidance planning, MR vs CT debate, functional MR Linac, AI & more— Who’s ready for deep dive into all things advanced imaging Southeast AAPM Symposium! Kicks off tomorrow Feb 8. Thanks to my co-director Megan Lipford & speakers.

Great showdown debate with The RSS gang! Roaring 20’ ! So proud to moderate the session with Stanley Benedict and thanks to outstanding speakers 🙏Kathryn Mittauer, PhD Rupesh Kotecha Joost Verhoeff and Dennis N Stanley #RSS2024

Grateful to work with/ all-star #MRgRT team over weekend to finish 5-fx intl pancreas pts before ✈️ home…had short downtime last week Pts w/ large LAPC growing on chemo told no options 🤨 Proving this is wrong!!! Durable metabolic CR w/ ablative RT is routine Miami Cancer Institute Research

Michael Chuong @kharofaJ William A Hall, MD Kathryn Mittauer, PhD presented this workflow at a Unity User’s Meeting in Dallas yesterday. Loved the “innovation”— using supplemental O2 to enhance breathhold duration. Will be adding that to our “tips and tricks” collection. That’s the beauty of best practice sharing. Great work!

Interesting case… 👉Stage II CRC (MSI-H) resected 👉Recurrence after ~1 yr in several nodes 👉Nodal progression on single-agent pembro 👉25 Gy/1 fx to only 1 node, continued pembro 👉Sustained response in ALL nodes while still on pembro 👉RT can salvage immune response 😎